Agilon Health (AGL) Cash from Investing Activities (2020 - 2026)

Agilon Health (AGL) has 7 years of Cash from Investing Activities data on file, last reported at $19.3 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 183.47% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.0 million (up 100.37% YoY) and the FY2025 annual result came in at $88.6 million, down 36.66% from the prior year.
• Cash from Investing Activities retreated to $19.3 million in Q1 2026, from $22.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $70.5 million in Q2 2025 to a low of -$296.6 million in Q2 2022.
• A 5-year average of -$14.2 million and a median of $18.2 million in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 1032.19% — and 2024, when it jumped 1174.58%.
• Tracing AGL's Cash from Investing Activities over 5 years: stood at -$8.0 million in 2022, then surged by 72.36% to -$2.2 million in 2023, then jumped by 1174.58% to $23.7 million in 2024, then dropped by 4.6% to $22.6 million in 2025, then fell by 14.66% to $19.3 million in 2026.
• The last three Cash from Investing Activities figures came in at $19.3 million (Q1 2026), $22.6 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.